BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12438254)

  • 1. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
    Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway.
    Young AP; Nagarajan R; Longmore GD
    Oncogene; 2003 Oct; 22(46):7209-17. PubMed ID: 14562049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBP1 induces growth arrest by repression of E2F-dependent transcription.
    Lai A; Marcellus RC; Corbeil HB; Branton PE
    Oncogene; 1999 Mar; 18(12):2091-100. PubMed ID: 10321733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rb/chromatin connection and epigenetic control: opinion.
    Ferreira R; Naguibneva I; Pritchard LL; Ait-Si-Ali S; Harel-Bellan A
    Oncogene; 2001 May; 20(24):3128-33. PubMed ID: 11420729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
    J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lin-35/Rb and RNAi pathways cooperate to regulate a key cell cycle transition in C. elegans.
    Ouellet J; Roy R
    BMC Dev Biol; 2007 Apr; 7():38. PubMed ID: 17466069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members.
    Young AP; Longmore GD
    Oncogene; 2004 Jan; 23(3):814-23. PubMed ID: 14737116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
    Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p16 induces transcriptional downregulation of the RB gene.
    Fang X; Jin X; Xu HJ; Liu L; Peng HQ; Hogg D; Roth JA; Yu Y; Xu F; Bast RC; Mills GB
    Oncogene; 1998 Jan; 16(1):1-8. PubMed ID: 9467937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional control by cell-cycle regulators: a review.
    Lania L; Majello B; Napolitano G
    J Cell Physiol; 1999 May; 179(2):134-41. PubMed ID: 10199552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.
    Frolov MV; Dyson NJ
    J Cell Sci; 2004 May; 117(Pt 11):2173-81. PubMed ID: 15126619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E2F1-3 transcription factors are essential for cellular proliferation.
    Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
    Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
    Araki K; Kawauchi K; Tanaka N
    Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E; Lipp M; Cremisi C
    Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression.
    Wang S; Fusaro G; Padmanabhan J; Chellappan SP
    Oncogene; 2002 Dec; 21(55):8388-96. PubMed ID: 12466959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.